| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 04/11/2002 | WO2001076572A3 Use of compatible solutes as substances having free radical scavenging properties |
| 04/11/2002 | WO2001032680A3 18-nor-steroids as selectively active estrogens |
| 04/11/2002 | US20020042926 Ovary-specific genes and proteins |
| 04/11/2002 | US20020042505 Novel human ion channel protein and polynucleotides encoding the same |
| 04/11/2002 | US20020042443 Estrogen agonist / antagonist metabolites |
| 04/11/2002 | US20020042435 Cyclic AMP-specific phosphodiesterase inhibitors |
| 04/11/2002 | US20020042427 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors |
| 04/11/2002 | US20020042415 Dipeptide derivatives |
| 04/11/2002 | CA2425712A1 Methods of modulating apoptosis by administration of relaxin agonists or antagonists |
| 04/11/2002 | CA2424222A1 Inhibitors of prenyl-protein transferase |
| 04/11/2002 | CA2424199A1 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 04/11/2002 | CA2423929A1 Carbohydrate-associated proteins |
| 04/11/2002 | CA2423860A1 Substituted 1-aminobutan-3-ol derivatives |
| 04/11/2002 | CA2423677A1 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
| 04/11/2002 | CA2423312A1 Condensed pyridoindole derivatives |
| 04/10/2002 | EP1194557A2 An interleukin-1 receptor antagonist and uses thereof |
| 04/10/2002 | EP1194545A2 Secreted polypeptides and corresponding polynucleotides |
| 04/10/2002 | EP1194525A2 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions |
| 04/10/2002 | EP1194429A1 Potassium channel openers |
| 04/10/2002 | EP1194421A1 Selective npy (y5) antagonists |
| 04/10/2002 | EP1194409A1 Pyrazolidinol compounds |
| 04/10/2002 | EP1194147A1 Arylthiazolidinedione and aryloxazolidinedione derivatives |
| 04/10/2002 | EP1194138A1 Nutritional supplements |
| 04/10/2002 | EP1089719B1 Transdermal therapeutic system containing hormones and crystallization inhibitors |
| 04/10/2002 | EP1087986B1 7.alpha.-methyl 19-nortestosterone undecanoate with androgenic activity |
| 04/10/2002 | EP1030845B1 Heterocyclic compounds having mmp and tnf inhibitory activity |
| 04/10/2002 | EP0819009B1 Ovulation triggering drugs comprising luteinising hormone |
| 04/10/2002 | EP0732329B1 Chroman derivative |
| 04/10/2002 | CN1344326A Petroviral vectors comprising functional and non-functional splice donor and splce acceptor sites |
| 04/10/2002 | CN1344321A Screening method |
| 04/10/2002 | CN1344268A Use of imidazo [1,5-a]pyrido[3,2-e]-pyrazinones as medicaments |
| 04/10/2002 | CN1344257A Fused pydiopyridazine inhibitors of cGMP phosphodiesterase |
| 04/10/2002 | CN1344163A Stabilized oral pharmaceutical compsn. contg. iodide and iodate and method |
| 04/10/2002 | CN1344155A Transnasal transport/immunisation with highly adaptable carriers |
| 04/10/2002 | CN1343505A Chinese medicine 'Ruan capsule' for treating mastoplasia |
| 04/09/2002 | US6369222 mGluR antagonists and a method for their synthesis |
| 04/09/2002 | US6369210 22012, human carboxypeptidase |
| 04/09/2002 | US6369113 Antidepressants, parkinson's disease |
| 04/09/2002 | US6369089 Interheteroaryl 7-oxabicyclic [2.2.1]heptane oxazoles as prostaglandin F2α antagonists |
| 04/09/2002 | US6369084 Prostaglandin mediated diseases |
| 04/09/2002 | US6369082 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 04/09/2002 | US6369059 Tetracyclic derivatives, process of preparation and use |
| 04/09/2002 | US6369056 Agonists and antagonists of the progesterone receptor; contraceptives; 6-(3-chlorophenyl)-4,4-dimethyl-1,4-dihydro -3-oxa-1,8-diaza-naphthalene-2-one and 6-chloro-4,4-dimethyl-1,4-dihydro-3-oxa-1,5-diaza-naphthalen-2-one |
| 04/09/2002 | US6369049 Treatment of mastitis |
| 04/09/2002 | US6369047 Androgenic steroid compounds and a method of making and using the same |
| 04/09/2002 | CA2090321C Therapeutically useful 2-aminotetralin derivatives |
| 04/04/2002 | WO2002026987A2 A human g-protein coupled receptor, hgprbmy6, expressed highly in small intestine |
| 04/04/2002 | WO2002026781A2 Ige receptor antagonists |
| 04/04/2002 | WO2002026774A2 Melanocortin receptor ligands |
| 04/04/2002 | WO2002026759A2 17α FLUOROALKYL STEROIDS, METHOD FOR PRODUCING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS |
| 04/04/2002 | WO2002026729A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 04/04/2002 | WO2002026727A2 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
| 04/04/2002 | WO2002026724A1 Cyclized benzamide neurokinin antagonists for use in therapy |
| 04/04/2002 | WO2002026704A1 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives of cyclopentyl-heptan(ene)oic acid as therapeutic agents |
| 04/04/2002 | WO2002026694A1 O-substituted 6-methyl-tramadol derivatives |
| 04/04/2002 | WO2002026223A2 Catecholamine pharmaceutical compositions and methods |
| 04/04/2002 | WO2002026193A2 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas |
| 04/04/2002 | WO2002004636A8 NOVEL α-CATENIN EXPRESSED IN HEART AND TESTIS |
| 04/04/2002 | WO2002000167A3 Modified forms of pharmacologically active agents and uses therefor |
| 04/04/2002 | WO2001097795A3 Systems and methods for treating a mucosal surface |
| 04/04/2002 | WO2001094347A8 Tetracyclic diketopiperazine compounds as pdev inhibitors |
| 04/04/2002 | WO2001090137A3 NOVEL SOLID BODY FORMS OF MESOPROGESTIN 11β-[4E-(HYDROXYIMINOMETHYL)-PHENYL]-17α-METHOXYMETHYL-17β-METHOXY-ESTRA-4,9-DIEN-3-ONE |
| 04/04/2002 | WO2001090079A3 Novel carbamates and carbamides, production and use thereof as endothelin receptor antagonists |
| 04/04/2002 | WO2001077294A3 Hpv-specific short-mers |
| 04/04/2002 | WO2001073034A3 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 04/04/2002 | WO2001073033A3 Anti-angiogenic and anti-tumor properties of matin and other laminin domains |
| 04/04/2002 | WO2001072839A3 Human g-protein coupled receptors |
| 04/04/2002 | WO2001062260A3 Improvement of implantation rate |
| 04/04/2002 | WO2001055178A9 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
| 04/04/2002 | WO2001053352A3 Sperm specific proteins |
| 04/04/2002 | WO2001050848A3 Clonal propagation of primate offspring by embryo splitting |
| 04/04/2002 | WO2001049715A3 Methods and compositions for inhibiting neoplastic cell growth |
| 04/04/2002 | US20020040150 Skin treatment compositons containing a cationic polymer and a microparticle or nanoparticle vector |
| 04/04/2002 | US20020040146 Useful as inhibitors of metalloproteases, e.g. zinc proteases, and which are effective in therapy of disease states associated with vasoconstriction |
| 04/04/2002 | US20020040139 Intranasal formulations for treating sexual disorders |
| 04/04/2002 | US20020040048 (2S,4R)-4-Mercapto-1-(naphthalene-2-sulfonyl)-pyrrolidine-2 -carboxylic acid N'-isobutyl-N'-(4-methyl-benzenesulfonyl)-hydrazide, for example; inhibitors of metalloproteases, e.g. zinc proteases; vasodilators |
| 04/04/2002 | US20020040021 Method for treating sexual dysfunction |
| 04/04/2002 | US20020040016 Derivatives of azetidine and pyrrolidine |
| 04/04/2002 | US20020040007 Novel macrolide antibiotics |
| 04/04/2002 | US20020039996 Pharmaceutical administration form for peptides, process for its preparation, and use |
| 04/04/2002 | DE10045380A1 Verfahren zur Kontrazeption und dessen Darreichungsform Method of contraception and its dosage form |
| 04/04/2002 | DE10043846A1 17-Methylensteroide, Verfahren zu deren Herstellung und diese Verbindung enthaltende pharmazeutische Zusammensetzungen 17-methyl steroids, processes for their preparation and pharmaceutical compositions containing this compound |
| 04/04/2002 | CA2424021A1 Catecholamine compositions and uses thereof |
| 04/04/2002 | CA2423954A1 A novel human g-protein coupled receptor, hgprbmy6, expressed highly in small intestine |
| 04/04/2002 | CA2423919A1 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
| 04/04/2002 | CA2423903A1 O-substituted 6-methyltramadol derivatives |
| 04/04/2002 | CA2423474A1 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives of cyclopentyl-heptan(ene)oic acid as therapeutic agents |
| 04/04/2002 | CA2423413A1 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas |
| 04/04/2002 | CA2423141A1 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 04/04/2002 | CA2422056A1 17.alpha. fluoroalkyl steroids, method for producing the same and pharmaceutical compositions containing said compounds |
| 04/04/2002 | CA2420577A1 Peptide-based compounds |
| 04/04/2002 | CA2420475A1 Ige receptor antagonists |
| 04/04/2002 | CA2420045A1 Melanocortin receptor ligands |
| 04/03/2002 | EP1193250A1 Phenyl sulfamate derivatives |
| 04/03/2002 | EP1192951A2 Pharmaceutical composition containing a compound having angiotensin II antagonistic activity in combination with another compound |
| 04/03/2002 | EP1192261A1 22025, a novel human cyclic nucleotide phosphodiesterase |
| 04/03/2002 | EP1192252A2 Secreted protein zacrp4 |
| 04/03/2002 | EP1192171A1 48 human secreted proteins |
| 04/03/2002 | EP1192165A2 Substituted heterocycle fused gamma-carbolines |
| 04/03/2002 | EP1192163A1 DITHIEPINO 6,5-b]PYRIDINES, AND RELATED COMPOSITIONS AND METHODS |